Clinical Trial

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

Name: Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) — clinical trial record (NCT07640776)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RELIEF

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and effectiveness of using Irreversible Electroporation (IRE) for the treatment of symptomatic benign prostatic hyperplasia (BPH).

Trial Details

NCT Number	NCT07640776
Lead Sponsor	Angiodynamics, Inc.
Conditions	Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Enrollment	40 participants
Start Date	2026-09
Primary Completion	2027-12 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-11